Hematologic changes associated with half-body irradiation in dogs with lymphoma.

Background: Reports describe the technique and efficacy of half-body irradiation (HBI) of dogs with lymphoma, but few describe the distinctive toxicoses associated with the combination of HBI and chemotherapy.

Hypothesis: HBI would transiently affect myelocytic and erythroid variables as assessed by serial analysis of complete blood counts.

Animals: Twenty-nine dogs with lymphoma treated with HBI during 2002 and 2003.